
Yevgeny Valenrod
Examiner (ID: 18322)
| Most Active Art Unit | 1621 |
| Art Unit(s) | 1628, 1621, 1672 |
| Total Applications | 1499 |
| Issued Applications | 1070 |
| Pending Applications | 102 |
| Abandoned Applications | 358 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15360801
[patent_doc_number] => 20200016165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES
[patent_app_type] => utility
[patent_app_number] => 16/320148
[patent_app_country] => US
[patent_app_date] => 2017-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320148
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320148 | Administration and dosage of diaminophenothiazines | Jul 24, 2017 | Issued |
Array
(
[id] => 14259009
[patent_doc_number] => 10279048
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Stabilizing excipients for therapeutic protein formulations
[patent_app_type] => utility
[patent_app_number] => 15/647669
[patent_app_country] => US
[patent_app_date] => 2017-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14909
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15647669
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/647669 | Stabilizing excipients for therapeutic protein formulations | Jul 11, 2017 | Issued |
Array
(
[id] => 12790534
[patent_doc_number] => 20180155347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING PERILLYL ALCOHOL DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 15/646682
[patent_app_country] => US
[patent_app_date] => 2017-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15646682
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/646682 | PHARMACEUTICAL COMPOSITIONS COMPRISING PERILLYL ALCOHOL DERIVATIVES | Jul 10, 2017 | Abandoned |
Array
(
[id] => 12029508
[patent_doc_number] => 20170319607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING SYMPTOMS OF DISEASES RELATED TO IMBALANCE OF ESSENTIAL FATTY ACIDS'
[patent_app_type] => utility
[patent_app_number] => 15/646342
[patent_app_country] => US
[patent_app_date] => 2017-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22423
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15646342
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/646342 | Methods and compositions for treating symptoms of diseases related to imbalance of essential fatty acids | Jul 10, 2017 | Issued |
Array
(
[id] => 12136457
[patent_doc_number] => 20180014540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'AQUEOUS SUSPENSION AGROCHEMICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/646447
[patent_app_country] => US
[patent_app_date] => 2017-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6856
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15646447
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/646447 | Aqueous suspension agrochemical composition | Jul 10, 2017 | Issued |
Array
(
[id] => 12253031
[patent_doc_number] => 09925161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Compounds for the treatment of obesity and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 15/644247
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 47
[patent_no_of_words] => 28946
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15644247
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/644247 | Compounds for the treatment of obesity and methods of use thereof | Jul 6, 2017 | Issued |
Array
(
[id] => 11979219
[patent_doc_number] => 20170283373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'Acid Mist Mitigation Agents for Electrolyte Solutions'
[patent_app_type] => utility
[patent_app_number] => 15/629416
[patent_app_country] => US
[patent_app_date] => 2017-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9726
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15629416
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/629416 | Acid Mist Mitigation Agents for Electrolyte Solutions | Jun 20, 2017 | Abandoned |
Array
(
[id] => 16052617
[patent_doc_number] => 20200188163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => THIXOTROPIC BINGHAM PLASTIC FLUID CONTRACEPTIVE METHOD
[patent_app_type] => utility
[patent_app_number] => 16/607880
[patent_app_country] => US
[patent_app_date] => 2017-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607880
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/607880 | THIXOTROPIC BINGHAM PLASTIC FLUID CONTRACEPTIVE METHOD | Jun 14, 2017 | Abandoned |
Array
(
[id] => 12118711
[patent_doc_number] => 20180002297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'Tetrazolones as a Carboxylic Acid Bioisosteres'
[patent_app_type] => utility
[patent_app_number] => 15/617900
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 29708
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15617900
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/617900 | Tetrazolones as a carboxylic acid bioisosteres | Jun 7, 2017 | Issued |
Array
(
[id] => 16336469
[patent_doc_number] => 10787413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Derivatives of curcuminoids and use thereof as an anticancer agent
[patent_app_type] => utility
[patent_app_number] => 16/098207
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 13126
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098207 | Derivatives of curcuminoids and use thereof as an anticancer agent | Jun 1, 2017 | Issued |
Array
(
[id] => 12091200
[patent_doc_number] => 20170348293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'METHOD OF TREATING LIVER FIBROSIS'
[patent_app_type] => utility
[patent_app_number] => 15/612124
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10591
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15612124
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/612124 | Method of treating liver fibrosis | Jun 1, 2017 | Issued |
Array
(
[id] => 11963517
[patent_doc_number] => 20170267670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'PIPERAZINE DERIVATIVES FOR TREATING DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/609596
[patent_app_country] => US
[patent_app_date] => 2017-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 22806
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15609596
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/609596 | Piperazine derivatives for treating disorders | May 30, 2017 | Issued |
Array
(
[id] => 17554886
[patent_doc_number] => 11311543
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => Compositions and methods for inhibiting PTPN22
[patent_app_type] => utility
[patent_app_number] => 16/304807
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 57
[patent_no_of_words] => 20514
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16304807
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/304807 | Compositions and methods for inhibiting PTPN22 | May 25, 2017 | Issued |
Array
(
[id] => 14578369
[patent_doc_number] => 20190216793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING NEGATIVE SYMPTOMS IN NON-SCHIZOPHRENIC PATIENTS
[patent_app_type] => utility
[patent_app_number] => 16/302722
[patent_app_country] => US
[patent_app_date] => 2017-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302722
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302722 | COMPOSITIONS AND METHODS FOR TREATING NEGATIVE SYMPTOMS IN NON-SCHIZOPHRENIC PATIENTS | May 22, 2017 | Abandoned |
Array
(
[id] => 14578343
[patent_doc_number] => 20190216780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => Use Of Carbamate Compound In Order To Preventatively Treat Headaches
[patent_app_type] => utility
[patent_app_number] => 16/302842
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4024
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302842
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302842 | Use of carbamate compound in order to preventatively treat headaches | May 17, 2017 | Issued |
Array
(
[id] => 11948154
[patent_doc_number] => 20170252305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'SODIUM TETRADECYL SULFATE FORMULATIONS FOR TREATMENT OF ADIPOSE TISSUE'
[patent_app_type] => utility
[patent_app_number] => 15/599170
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17104
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599170
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/599170 | SODIUM TETRADECYL SULFATE FORMULATIONS FOR TREATMENT OF ADIPOSE TISSUE | May 17, 2017 | Abandoned |
Array
(
[id] => 13814333
[patent_doc_number] => 10183927
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-22
[patent_title] => Crystalline forms of C
[patent_app_type] => utility
[patent_app_number] => 15/598181
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20315
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15598181
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/598181 | Crystalline forms of C | May 16, 2017 | Issued |
Array
(
[id] => 11941987
[patent_doc_number] => 20170246138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'METHOD OF TREATING OR PREVENTING TUMORS USING 1-(ALKYLSULFINYL)-2-ISOTHIOCYANATOALKYL-1-ALKENE'
[patent_app_type] => utility
[patent_app_number] => 15/597116
[patent_app_country] => US
[patent_app_date] => 2017-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8669
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15597116
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/597116 | METHOD OF TREATING OR PREVENTING TUMORS USING 1-(ALKYLSULFINYL)-2-ISOTHIOCYANATOALKYL-1-ALKENE | May 15, 2017 | Abandoned |
Array
(
[id] => 12282970
[patent_doc_number] => 09931303
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-04-03
[patent_title] => Abuse deterrent formulations of amphetamine
[patent_app_type] => utility
[patent_app_number] => 15/591677
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 81
[patent_figures_cnt] => 138
[patent_no_of_words] => 33169
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15591677
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/591677 | Abuse deterrent formulations of amphetamine | May 9, 2017 | Issued |
Array
(
[id] => 12204798
[patent_doc_number] => 20180050024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => '4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/591419
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21378
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15591419
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/591419 | 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds | May 9, 2017 | Issued |